Genentech Becomes Ensemble Therapeutics’ Third Big Pharma Collaborator on Macrocyclic Drug Discovery |
Abstract
|
Heather Cartwright |
|
Forest Gains Takeover Option in Antibiotic Development Deal with Nabriva Therapeutics |
Abstract
|
Heather Cartwright |
|
Genmab’s DuoBody™ Technology Gains Validation with Novartis Collaboration |
Abstract
|
Heather Cartwright |
|
Merck KGaA Ventures into Biosimilars in Collaboration with Dr. Reddy’s |
Abstract
|
Heather Cartwright |
|
Genentech and AC Immune Partner Again in Alzheimer’s Disease |
Abstract
|
Heather Cartwright |
|
Merck & Co. Forays into Biologic-Drug Conjugates in Collaboration with Ambrx |
Abstract
|
Heather Cartwright |
|
GSK’s Stiefel Laboratories Acquires Welichem Biotech’s Mid-Stage Psoriasis and Atopic Dermatitis Drug |
Abstract
|
Heather Cartwright |
|
Baxter Pursues Haemophilia B Gene Therapy with Chatham Therapeutics Collaboration |
Abstract
|
Heather Cartwright |
|
GSK Strengthens its Dermatology Business with Acquisition of Basilea’s Toctino® |
Abstract
|
Heather Cartwright |
|
UCB Accesses Brazilian Market by Acquiring Majority Stake in Meizler Biopharma |
Abstract
|
Heather Cartwright |
|
Newron Moves to Acquire Swedish Neurogenesis Company NeuroNova |
Abstract
|
Heather Cartwright |
|
Upsher-Smith to Take Over CNS Partner Proximagen |
Abstract
|
Heather Cartwright |
|
Consolidation and Differentiation: Key Drivers of Change in the Global Pharmaceutical Manufacturing Industry |
Abstract
|
Cynthia Tso, Jansen Jacob |
|